Auf der Medizin 2020 vom 7. bis 9. Februar 2020 hat der Verein einen gemeinsamen Verstand mit dem Senior Experten Service (SES Bonn) mit dem er auf seinen Auslandseinsätzen kooperiert um beide gemeinnützigen Einrichtungen besser in der Öffentlichkeit bekannt zu machen. Die beiden Dateien beschreiben … Continue reading “Medizin 2020 in Stuttgart, Germany”
Author: Kurt-Wilhelm Stahl
Give Hope Now to Patients with Skin NTDs in the Middle East and Africa
On August 30th, 2017, the German Regulatory Drug and Medical Device Agency, BfArM, has granted a special approval, i.e. a temporary market access for the wound healing device LeiProtect®, developed by our NGO, Waisenmedizin e.V., to treat wounds of neglected tropical skin diseases. In contrast … Continue reading “Give Hope Now to Patients with Skin NTDs in the Middle East and Africa”
Agreement of Scientific Cooperation
Waisenmedizin e.V. Freiburg and the Algerian Pasteur Institute (API) have signed an agreement of scientific cooperation (Convention particulière portant sur le projet “Contrôle de la Leishmaniose Cutanée en Algérie du 20 janvier 2017”). Since the political turmoil started in Algeria this cooperation is, presently (August … Continue reading “Agreement of Scientific Cooperation”
Hand-Hygiene Propagation in the biggest MENA country, Algeria
Together with the Directorate-General of Prevention and Health Promotion at the Algerian Ministry of Health, Prof. Zoubir Harrat, Director-General of the Institut Pasteur d’Algérie (IPA), is committed to effectively propagating hand hygiene in Algeria. Hand disinfection advocated by WHO with alcohol-based hand rub (ABHR) is crucial … Continue reading “Hand-Hygiene Propagation in the biggest MENA country, Algeria”
Temporary Market Access granted by BfArM for the Medical Device, LeiProtect®
The use of LeiProtect® has been legalized on August 28th, 2017 (91.1.07-5640-S-006/16) by the Institut für Arzneimittel und Medizinprodukte (BfArM) according to § 11 of the Medical Device Regulation (MPG). It is currently used to protect leishmaniasis skin lesions from superinfections, thus promoting their healing, … Continue reading “Temporary Market Access granted by BfArM for the Medical Device, LeiProtect®”